Mode of photoexcited C₆₀ fullerene involvement in potentiating cisplatin toxicity against drug-resistant L1210 cells

Daria Franskevych ¹ , Svitlana Prylutska ¹ * , Iryna Grynyuk ¹ , Ganna Pasichnyk ² , Liudmyla Drobot ² , Olga Matyshevska ^1,2 , Uwe Ritter ³

Cited by CrossRef: 2

1- Cheng Z, Li M, Dey R, Chen Y. Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol. 2021;14(1) [Crossref]

2- Mirzaei S, Hushmandi K, Zabolian A, Saleki H, Torabi S, Ranjbar A, SeyedSaleh S, Sharifzadeh S, Khan H, Ashrafizadeh M, Zarrabi A, Ahn K. Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies. Molecules. 2021;26(8):2382 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons

Original Research

Mode of photoexcited C60 fullerene involvement in potentiating cisplatin toxicity against drug-resistant L1210 cells

Cited by CrossRef: 2

Mode of photoexcited C₆₀ fullerene involvement in potentiating cisplatin toxicity against drug-resistant L1210 cells